CorVel Corporation (CRVL) - Forward P/S Multiple

Corporate emblem and logo of CorVel Corp (CRVL)

Despite CorVel Corporation (CRVL) pivoting away from mergers in favor of organic growth via API, the company has established a formidable defensive moat through its AI-driven payment optimization systems. The forward P/S trajectory on the GURU.Markets portal reflects market expectations, where the 4.30 mark serves as the current benchmark. This confirms the brand's leadership in automating workers' compensation insurance expenses to reduce employer costs.

CRVL CorVel: Market Cap to Future Revenue Ratio in the range 07/04/2022 - 11/15/2026

Financial and market metric breakdowns for corvel.com (CRVL)

- stock price and consensus target price:
Initial company analysis:CRVL (CorVel Healthcare)
Original product of CorVel Corporation

Unique software for medical claims management and resilient relationships with insurers provide CorVel Corporation (CRVL) with a protected market niche. Analyzing this forward price-to-sales chart, an investor can see the ratio of market capitalization to expected sales, which allows for determining the premium paid for future growth and assessing the efficiency of the business model under strict regulatory control.

Key competitors

Price-to-Projected Revenue Ratio Veeva Corp VEEV|Price to Expected Revenue Ratio DOCS (Doximity, Inc.)|HQY: Forward Price-to-Revenue Multiple|Forward Price to Sales WAY (waystar.com)|PRVA: Forward P/S Multiple|Market Cap to Projected Revenue HURN|Price-to-Projected Revenue Ratio Certara, Inc.|Omnicell Health (OMCL) - Market Cap to Expected Sales Ratio|Forward P/S Multiple GDRX|SDGR (Schrödinger) - Forward Price to Sales|Phreesia Inc - Forward Price-to-Revenue Multiple|Forward Price to Sales OMDA|Evolent - Forward P/S Multiple|Forward Price to Sales HSTM (HealthStream Corp)|DH (Definitive Healthcare Inc.) - Forward Price-to-Revenue Multiple|Consensus Cloud Solutions (CCSI) - Forward P/S Multiple|Price-to-Projected Revenue Ratio agilon health|Market Cap to Projected Revenue ABSI (Absci Corporation)|Forward P/S Multiple SY|NRC (National Research Corp) - Forward Price to Sales|Forward P/S Multiple SPOK (spok.com)|Forward Price to Sales OPRX|trubridge.com - Forward P/S Multiple|SLP (Simulations Plus) - Market Cap to Projected Revenue|SOPHiA GENETICS SA (SOPH) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Health Catalyst, Inc.|Forward Price-to-Revenue Multiple CCLD|researchsolutions.com (RSSS) - Market Cap to Expected Sales Ratio|Forward P/S Multiple DLHC|OneMedNet Corp - Market Cap to Projected Revenue|Forward P/S Multiple SCNX (Scienture Corp)|Price to Expected Revenue Ratio HCTI (Healthcare Triangle Corp)|iSpecimen Corp - Forward P/S Multiple|Forward Price to Sales BFRG (bullfrogai.com)|WORX: Forward P/S Multiple|Forward Price-to-Revenue Multiple MSP Recovery|Price-to-Projected Revenue Ratio icoreconnect.com|MEDS: Forward Price to Sales|Price-to-Projected Revenue Ratio Orgenesis Inc. (ORGS)|Market Cap to Expected Sales Ratio R1 RCM, Inc.|Forward P/S Multiple SHCR (sharecare.com)|Market Cap to Expected Sales Ratio Streamline Health Solutions, Inc. (STRM)|SYRA - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio Apollo Medical Holdings Inc. AMEH|Model N (MODN) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue NXGN